A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

NCT04070495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6356
DRUG: Clarithromycin
DRUG: Rifampicin

Sponsor

Kyowa Kirin Co., Ltd.